With half a million children affected by food allergies attending US summer camps, access to emergency epinephrine is critical. A study, released by the American Academy of Pediatrics, uses a cost-effectiveness model to demonstrate that stocking epinephrine at camps is the most effective and cost-effective strategy for managing anaphylaxis. Stock epinephrine not only reduces hospitalizations but also provides better health outcomes at a lower cost than relying solely on individuals to bring their own. The research supports wider adoption of stock epinephrine policies, especially as costs decrease and allergy risks rise.
Read the full article here.